Clinical and hematologic effects of triethylene melamine

This publication has 28 references indexed in Scilit:

• Triethylene melamine in clinical cancer chemotherapy
  The American Journal of Medicine, 1952
• Triäthylenmelamin (Tem), ein neuer Stoff zur Behandlung von Leukämien
  Journal of Molecular Medicine, 1952
• Clinical observations on the use of triethylenemelamine
  Cancer, 1952
• Triethylene Melamine Therapy in Hodgkin's and other Malignant Diseases
  Acta Radiologica, 1951
• UREMIA COMPLICATING LEUKEMIA CHEMOTHERAPY
  JAMA, 1951
• TRIETHYLENE MELAMINE IN THE TREATMENT OF NEOPLASTIC DISEASE
  A.M.A. Archives of Internal Medicine, 1951
• Trisethyleneimino-s-Triazine in Human Malignant Disease: A Preliminary Trial
  British Journal of Cancer, 1951
• NITROGEN MUSTARD THERAPY IN HODGKIN’S DISEASE
  Blood, 1949
• Effect of Urethane on Malignant Diseases: Clinical, Hematologic and Histologic Observations on Patients with Carcinoma, Leukemia and Related Diseases
  American Journal of Clinical Pathology, 1948
• NITROGEN MUSTARD THERAPY
  JAMA, 1946